Coral Genomics

Coral develops new clinical tests to help providers streamline prior authorization and select the most effective medication for a particular patients focusing on autoimmune conditions such as Inflammatory Bowel Disease and Rheumatoid Arthritis. It has also identified a unique population of non-responder patients and is working with drug developersto address this unmet medical need.